Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pure Global Cannabis Inc PRCNF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Pure Global Cannabis Inc is a growth-oriented life science cannabis company led by experienced pharma-industry, horticultural and supply chain experts.


GREY:PRCNF - Post by User

Pure Global Cannabis Inc > CEO Interview
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by lifegoesonon Dec 21, 2018 2:53pm
68 Views
Post# 29147813

RE:RE:CEO Interview

RE:RE:CEO InterviewMakingIT, it is obvious why insiders stopped buying and why the support in the market is thin. We are now back at pennies, with no cannabis to sell and significant number of shares outstanding. The $10M deal they lost was clearly critical to cannabis supply. This group is turning out to be another company that should never, never have gone Public, and guess what, everyone who bought at higher prices is paying for inexperienced Public Market players.... too bad, now we are really on the long tail curve...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities